Navigating the Indecisive SPY: What Investors Should Know
When running my StockCharts Technical Rank (SCTR) scan on Thursday, I was a little surprised to find that 75 exchange-traded...
Latest News
Skyharbour Announces Closing of Private Placement for Gross Proceeds of C$10 Million
Not For Distribution to U.S. News Wire Services or Dissemination in The United States Vancouver, BC, Dec. 20, 2024 (GLOBE...
FALCO ANNOUNCES CLOSING OF BROKERED PRIVATE PLACEMENT
/NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES / TSXV – FPC Falco...
Stock Futures Lower after S&P 500 futures ticked down 0.18%
Stock futures are trading slightly lower Monday morning as investors gear up for the final month of 2024. S&P 500...
S&P 500 climbed 0.3%, and Nasdaq-100 futures jumped 0.7%
Stock futures climbed on Wednesday, driven by strong performances from Salesforce and Marvell Technology, following upbeat quarterly earnings. Futures tied...
Big Lots initiates going-out-of-business sales at remaining locations
Troubled discount furniture and home decor retailer Big Lots will initiate going-out-business sales at its remaining locations after a deal...
Trump transfers all his DJT shares to his revocable trust, SEC filings show
President-elect Donald Trump this week transferred his entire stake of shares in Trump Media to a revocable trust of which he is the sole beneficiary, regulatory filings revealed...
The Big Divergence in Bullish Percents
While the S&P 500 and Nasdaq 100 have been holding steady into this week’s Fed meeting, warning signs under the...
Forum Comments on Share Price
Forum Energy Metals Corp. (TSXV: FMC) (OTCQB: FDCFF) (‘Forum’ or the ‘Company’) announced today that the Company is not aware...
PRISM MarketView Features Q&A with President and CEO David Elsley: Cardiol Therapeutics Enters Phase 3 Clinical Trial for CardiolRx Addressing Patients with Recurrent Pericarditis
Cardiol Therapeutics President and CEO, David Elsley PRISM MarketView announces the release of an informative interview with Cardiol Therapeutics President...
